Neuromedical Systems v. NeoPath
This article was originally published in The Gray Sheet
Executive Summary
United States federal district court in New York refuses to grant a preliminary injunction enjoining NeoPath from manufacturing and selling its AutoPap 300 QC system, Neuromedical Systems announces in a May 27 release. The court orders the parties to complete the discovery phase of the suit and return for a pretrial conference by the end of August, NSI adds. The company filed suit in July 1996, alleging that NeoPath "willfully misappropriated" NSI's Papnet automated cervical cytology reader technology and used the technology in the NeoPath AutoPap 300 QC ("The Gray Sheet" July 22, 1996, In Brief). NeoPath later filed suit in March 1997 in the U.S. District Court in Seattle claiming that NSI infringes three NeoPath patents ("The Gray Sheet" April 7, 1997, In Brief)